Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Biopharmx Corporatio (BPMX)

0.2449 -0.0451 (-15.5517%)

10/20/2017  4:00pm

Open:

0.2399

Pre. Close:

0.2900

High:

0.2700

Low:

0.2200

Volume:

3,280,777

Market Cap:

19.51M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.28 - 0.28

0.28 - 0.29

Low:

0.21 - 0.21

0.21 - 0.22

Close:

0.23 - 0.23

0.23 - 0.24

Technical analysis  (as of: 2017-10-20 4:34:01 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 0.35     One year: 0.41

Support:

Support1: 0.22    Support2: 0.18

Resistance:

Resistance1: 0.30    Resistance2: 0.35

Pivot:

0.29

Moving Averages:

MA(5): 0.28     MA(20): 0.29

MA(100): 0.37     MA(250): 0.43

MACD:

MACD(12,26): -0.01     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 27.85     %D(3): 23.47

RSI:

RSI(14): 35.57

52-Week:

High: 0.8970  Low: 0.1880  Change(%): -12.5

Average Vol(K):

3-Month: 86745  10-Days 80305

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
BPMX has closed below the lower band by 34.0%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 59.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to BPMX's normal range. The bands have been in this narrow range for 49 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 19 Oct 2017 21:11:15 GMT
Biopharmx Corp (NYSE:BPMX) Sees Significant Growth in Short Interest

Thu, 19 Oct 2017 12:33:45 GMT
Why to Keeping Eye on SBA Communications Corporation (SBAC), BioPharmX ...

Sat, 30 Sep 2017 04:52:30 GMT
Biopharmx Corp (NASDAQ:BPMX) Given Buy Rating at HC Wainwright

Fri, 29 Sep 2017 03:33:45 GMT
Biopharmx Corp (NASDAQ:BPMX) Announces Earnings Results, Meets Estimates

Sat, 21 Oct 2017 19:30:00 GMT
Align Technology, Inc. (NASDAQ:ALGN) and BioPharmX Corporation (:BPMX) See ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

79.00

Shares Float (M)

58.57

% Held by Insiders

9.78

% Held by Institutions

39.44

Shares Short (K)

5320

Shares Short Prior Month (K)

5410

Stock Financials

EPS

-0.315

EPS Est. Current Year

-0.240

EPS Est. Next Year

-0.390

EPS Est. Next Quarter

-0.070

Forward EPS

-0.321

Book Value (p.s.)

-0.005

PEG Ratio

Profit Margin

Operating Margin

-21602.38

Return on Assets (ttm)

-342.8

Return on Equity (ttm)

Qtrly Rev. Growth

-10.5

Gross Profit (p.s.)

-0.005

Sales Per Share

0.001

EBITDA (p.s.)

-0.229

Qtrly Earnings Growth

Operating Cash Flow (M)

-16.93

Levered Free Cash Flow (M)

-10.24

FoxReading.com

Valuation

P/E

-0.78

P/E Growth Ratio

-0.16

P/BV

-48.98

P/S

230.33

P/CF

-1.14

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.